Literature DB >> 28707109

The Assessment of Cough in a Sarcoidosis Clinic Using a Validated instrument and a Visual Analog Scale.

Marc A Judson1, Amit Chopra2, Edward Conuel3, Efstratios Koutroumpakis3, Christopher Schafer3, Adam Austin3, Robert Zhang3, Kerry Cao3, Rani Berry3, Malik M H S Khan2, Aakash Modi2, Ritu Modi3, Stephanie Jou3, Furqan Ilyas2, Recai M Yucel4.   

Abstract

PURPOSE: Cough is a common symptom of pulmonary sarcoidosis. We analyzed the severity of cough and factors associated with cough in a university sarcoidosis clinic cohort.
METHODS: Consecutive patients completed the Leicester Cough Questionnaire (LCQ) and a cough visual analog scale (VAS). Clinical and demographic data were collected. Means of the LCQ were analyzed in patients who had multiple visits in terms of constant variables (e.g., race, sex).
RESULTS: 355 patients completed the LCQ and VAS at 874 visits. Cough was significantly worse in blacks than whites as determined by the LCQ-mean (16.5 ± 2.6 vs. 17.8 ± 3.0, p < 0.001) and VAS-mean (3.8 ± 3.0 vs. 2.0 ± 2.6, p < 0.0001). Cough was worse in women than men as measured by the VAS-mean (2.7 ± 2.9 vs. 2.2 ± 2.7, p = 0.002), one of the LCQ-mean domains (LCQ-Social-mean 5.4 ± 0.9 vs. 5.2 ± 1.0, p = 0.03), but not the total LCQ-mean score. Cough was not significantly different by either measure in terms of smoking status, age, or spirometric parameter (FVC % predicted, FEV1 % predicted, FEV1/FVC). In a multivariable linear regression analysis, cough was significantly worse in blacks than whites and in pulmonary sarcoidosis than non-pulmonary sarcoidosis with both cough measures, in women than men for the VAS only, and not for spirometric parameters, Scadding stage, or age. The LCQ and VAS were strongly correlated.
CONCLUSIONS: In a large university outpatient sarcoidosis cohort, cough was worse in blacks than whites. Cough was not statistically significantly different in terms of age, spirometric measures, Scadding stage, or smoking status. The LCQ correlated strongly with a visual analog scale for cough.

Entities:  

Keywords:  Cough; Race; Sarcoidosis; Spirometry

Mesh:

Year:  2017        PMID: 28707109     DOI: 10.1007/s00408-017-0040-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  36 in total

1.  Löfgren's syndrome revisited: a study of 186 patients.

Authors:  J Mañá; C Gómez-Vaquero; A Montero; A Salazar; J Marcoval; J Valverde; F Manresa; R Pujol
Journal:  Am J Med       Date:  1999-09       Impact factor: 4.965

Review 2.  How best to measure cough clinically.

Authors:  Surinder S Birring; Arietta Spinou
Journal:  Curr Opin Pharmacol       Date:  2015-03-25       Impact factor: 5.547

3.  Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Lung       Date:  2016-10-05       Impact factor: 2.584

4.  Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Authors:  Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

5.  Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients.

Authors:  Mary-Margaret Lewis; Michael P Mortelliti; Henry Yeager; Edward Tsou
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2002-06       Impact factor: 0.670

6.  Non-specific bronchial reactivity and ultrastructure of the airway epithelium in patients with sarcoidosis and allergic alveolitis.

Authors:  L A Laitinen; T Haahtela; T Kava; A Laitinen
Journal:  Eur J Respir Dis Suppl       Date:  1983

7.  Racial differences in sarcoidosis granuloma density.

Authors:  Robert R Burke; Chad H Stone; Suzanne Havstad; Benjamin A Rybicki
Journal:  Lung       Date:  2008-08-21       Impact factor: 2.584

8.  The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States.

Authors:  M A Judson; A D Boan; D T Lackland
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-10       Impact factor: 0.670

9.  The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough.

Authors:  S S Birring; T Fleming; S Matos; A A Raj; D H Evans; I D Pavord
Journal:  Eur Respir J       Date:  2008-01-09       Impact factor: 16.671

10.  Cough, sarcoidosis and idiopathic pulmonary fibrosis: raw nerves and bad vibrations.

Authors:  Nicholas Kim Harrison
Journal:  Cough       Date:  2013-03-06
View more
  3 in total

1.  Predictors of cough-specific and generic quality of life in sarcoidosis patients.

Authors:  Branislav S Gvozdenovic; Violeta V Mihailovic-Vucinic; Mira H Vukovic; Mihailo I Stjepanovic; Ivana Buha; Strahinja V Mihailovic; Nikola B Maric
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

2.  Retrospective Study of Factors Potentially Influencing Occurrence of Cough in Slovak Patients with Sarcoidosis.

Authors:  Eva Kovacova; Robert Vysehradsky; Ivan Kocan; Jana Plevkova; Tomas Buday
Journal:  Can Respir J       Date:  2019-06-02       Impact factor: 2.409

3.  Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis.

Authors:  Jonas Christian Schupp; Urs Alexander Fichtner; Björn Christian Frye; Katja Heyduck-Weides; Surinder S Birring; Wolfram Windisch; Carl-Peter Criée; Joachim Müller-Quernheim; Erik Farin
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.